Testing version — LOERadar is in active testing. Features and data may change.
MAXALT-MLT (RIZATRIPTAN BENZOATE) | LOERadar
MAXALT-MLT
NDA
RIZATRIPTAN BENZOATE | N020865 | ORGANON LLC A SUB OF ORGANON AND CO
2 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (2)
Sort:
#001 — EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLD
0 patents0 exclusivities▴
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Jun 29, 1998
No patent or exclusivity listings for this strength.
#002 — EQ 10MG BASE
RLDAB
0 patents0 exclusivities▾
TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Jun 29, 1998